Stephen M. Ansell, MD, PhD of Mayo Clinic discusses the promising and exciting new results from CAR T-Cell data for treatment of not only mesothelioma but other difficult-to-treat diseases. This was recorded at the ASCO-SITC Clinical Immuno-Oncology Symposium in Orlando, Florida.
New CAR T-Cell Data for Treatment of Mesothelioma Looks Very Promising
